Human p53264–272 HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic mice

This publication has 31 references indexed in Scilit:

• Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
  The Journal of Experimental Medicine, 1997
• DNA-Mediated Immunization in Mice Induces a Potent MHC Class I-Restricted Cytotoxic T Lymphocyte Response to the Hepatitis B Envelope Protein
  Human Gene Therapy, 1995
• Overview of DNA Vaccines
  Annals of the New York Academy of Sciences, 1995
• T Cell‐Mediated Cytotoxicity Against p53‐Protein Derived Peptides in Bulk and Limiting Dilution Cultures of Healthy Donors
  Scandinavian Journal of Immunology, 1995
• MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
  Cell, 1994
• Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
  Cell, 1993
• In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
  European Journal of Immunology, 1993
• p53, guardian of the genome
  Nature, 1992
• Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
  Nature, 1991
• Allo-class i-reactive cd4-cd8- t cell hybridomas recognize the conformational change of class i molecule resulting from the exchange of the α3 domain
  European Journal of Immunology, 1989